Search

Daretta A Yursis

from Port Deposit, MD
Age ~58
Get Report
Also known as:
Daretta A Bruchey, Daretta Ann Bruchey, Daretta A Burchey, Daretta A Bruchui, Bruchey Bruchey, Daretta Y
Related to:
Willie BrucheyD YursisDaretta Ann Bruchey, 82William J Bruchey, 57William J Bruchey, 82Veronica B YursisGerard A Yursis, 64Elizabeth J Bruchey, 45Nathaniel D Bruchey, 55Elizabeth D Hays, 45Alex Yursis
Connected to:
Can Yurt, 54Evelyn C Yurt, 59Lynda Yurtch, 66Jennifer E Yurth, 51Tanju Yurtsever, 59Necdet Yurttan, 79Nese Yurttas, 54Julia Yuryev, 41Yuri Yuryev, 49Eva M Yusa, 55

Daretta Yursis Phones & Addresses

  • Port Deposit, MD
  • 1104 Mount Carmel Rd, Parkton, MD 21120 (410) 343-0901 (410) 343-0910
  • Timonium, MD
  • Cockeysville, MD
  • 1104 Mount Carmel Rd, Parkton, MD 21120

Publications

Us Patents

Detection Of Herpes Simplex Virus Types 1 And 2 By Nucleic Acid Amplification

View page
US Patent:
7291488, Nov 6, 2007
Filed:
Apr 26, 2004
Appl. No.:
10/832120
Inventors:
David M. Wolfe - Red Lion PA, US
Christine A. Martinaitis - Columbia MD, US
Daretta A. Yursis - Parkton MD, US
Assignee:
Becton, Dickinson & Company - Franklin Lakes NJ
International Classification:
C12P 19/24
C07H 21/02
C07H 21/04
C12Q 1/68
US Classification:
435 912, 536 231, 435 6
Abstract:
The present invention relates to a method of detecting the presence or absence of herpes simplex virus (HSV) in a sample based on amplifying a portion of the Glycoprotein G (US4) gene of HSV and detecting the presence of the amplified nucleic acid using primers and detector primers as described herewith. The method of the invention further identifies the type of HSV, either HSV-1 or HSV-2, in a sample. Also encompassed by the invention is a kit comprising the primers and detector primers which may be used with the amplification method described herewith.

Assay For Sars Coronavirus By Amplification And Detection Of The Replicase Sequence

View page
US Patent:
7521185, Apr 21, 2009
Filed:
Sep 13, 2004
Appl. No.:
10/570704
Inventors:
Jianrong Lou - Boyds MD, US
Daretta A. Yursis - Parkton MD, US
David M. Wolfe - Red Lion PA, US
Lisa M. Keller - York PA, US
Tobin J. Hellyer - Westminster MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/68
US Classification:
435 6, 435 911, 435 912, 536 2433
Abstract:
Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the replicase gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARS-CoV infection.

Assay For Sars Coronavirus By Amplification And Detection Of The Replicase Sequence

View page
US Patent:
7723041, May 25, 2010
Filed:
Feb 3, 2009
Appl. No.:
12/322520
Inventors:
Jianrong Lou - Boyds MD, US
Daretta A. Yursis - Parkton MD, US
David M. Wolfe - Red Lion PA, US
Lisa M. Keller - York PA, US
Tobin Hellyer - Westminster MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/68
US Classification:
435 6, 435 911, 435 912, 536 2433
Abstract:
Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the replicase gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARS-CoV infection.

Detection Of Herpes Simplex Virus Types 1 And 2 By Nucleic Acid Amplification

View page
US Patent:
7947820, May 24, 2011
Filed:
Jun 28, 2007
Appl. No.:
11/769829
Inventors:
David M. Wolfe - Red Lion PA, US
Christine A. Martinaitis - Columbia MD, US
Daretta A. Yursis - Parkton MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C07H 21/02
US Classification:
536 231, 435975
Abstract:
The present invention relates to a method of detecting the presence or absence of herpes simplex virus (HSV) in a sample based on amplifying a portion of the Glycoprotein G (US4) gene of HSV and detecting the presence of the amplified nucleic acid using primers and detector primers as described herewith. The method of the invention further identifies the type of HSV, either HSV-1 or HSV-2, in a sample. Also encompassed by the invention is a kit comprising the primers and detector primers which may be used with the amplification method described herewith.

Detection Of Herpes Simplex Virus Types 1 And 2 By Nucleic Acid Amplification

View page
US Patent:
8221976, Jul 17, 2012
Filed:
Apr 4, 2011
Appl. No.:
13/079452
Inventors:
David M. Wolfe - Red Lion PA, US
Christine Martinaitis - Columbia MD, US
Daretta A. Yursis - Parkton MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/68
C07H 21/04
US Classification:
435 61, 536 2433
Abstract:
The present invention relates to a method of detecting the presence or absence of herpes simplex virus (HSV) in a sample based on amplifying a portion of the Glycoprotein G(US4) gene of HSV and detecting the presence of the amplified nucleic acid using primers and detector primers as described herewith. The method of the invention further identifies the type of HSV, either HSV-1 or HSV-2, in a sample. Also encompassed by the invention is a kit comprising the primers and detector primers which may be used with the amplification method described herewith.

Method For Providing Long Term Stability To Cells For Diagnostic Testing

View page
US Patent:
20010016317, Aug 23, 2001
Filed:
Sep 13, 1999
Appl. No.:
09/395677
Inventors:
DOLORES M. BERGER - BALTIMORE MD, US
DARETTA A. YURSIS - PARKTON MD, US
WILLIAM A. NUSSBAUMER - TIMONIUM MD, US
ANNE B. BROWN - SEAFORD NY, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The present invention relates to a method and composition for stabilizing clinical specimens (i.e., cells in biological samples) for transport and subsequent testing for diagnosis. The composition is specifically capable of maintaining nucleic acid in the cells intact for hybridization with oligonucleotide capture and detector probes.

Composition For Providing Long Term Stability To Cells For Diagnostic Testing

View page
US Patent:
20020009722, Jan 24, 2002
Filed:
Sep 10, 1999
Appl. No.:
09/394006
Inventors:
DOLORES M. BERGER - BALTIMORE MD, US
DARETTA A. YURSIS - PARKTON MD, US
WILLIAM A. NUSSBAUMER - TIMONIUM MD, US
ANNE B. BROWN - SEAFORD NY, US
International Classification:
C12Q001/68
G01N033/53
G01N033/567
G01N033/569
US Classification:
435/006000, 435/007100, 435/007200, 435/007210, 435/007300
Abstract:
The present invention relates to a method and composition for stabilizing clinical specimens (i.e., cells in biological samples) for transport and subsequent testing for diagnosis. The composition is specifically capable of maintaining nucleic acid in the cells intact for hybridization with oligonucleotide capture and detector probes.

Assay For Sars Coronavirus By Amplification And Detection Of Nucleocapsid Rna Sequence

View page
US Patent:
20100136513, Jun 3, 2010
Filed:
Sep 13, 2004
Appl. No.:
10/570781
Inventors:
Jianrong Lou - Boyds MD, US
Daretta A. Yursis - Parkton MD, US
David M. Wolfe - Red Lion PA, US
Lisa M. Keller - York PA, US
Tobin J. Hellyer - Westminster MD, US
International Classification:
C12Q 1/70
C07H 21/04
C12P 19/34
C12Q 1/68
US Classification:
435 5, 536 2433, 435 912, 435 6
Abstract:
Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the nucleocapsid gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARSCoV infection.
Control profile
Daretta A Yursis from Port Deposit, MD, age ~58 Get Report